Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells

British Journal of Haematology

Volumn 151, Issue 3, 2010, Pages 252-264

  Poggi, Alessandro ^a   Prevosto, Claudia ^b   Catellani, Silvia ^a   Rocco, Ilaria ^a   Garuti, Anna ^a   Zocchi, Maria R ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bax; Bcl 2; Bcl x L; NF kB.; PECAM 1

Indexed keywords

CD31 ANTIGEN; CD68 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA; VIMENTIN; CD38 ANTIGEN; CD38 PROTEIN, HUMAN; HETEROPHILE ANTIBODY; MEMBRANE PROTEIN; TUMOR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; CELL ADHESION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE;

AGED; AGED, 80 AND OVER; ANTIBODIES, HETEROPHILE; ANTIGENS, CD31; ANTIGENS, CD38; APOPTOSIS; CELL ADHESION; CELL SURVIVAL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 79952111400     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08343.x     Document Type: Article

References (45)

1. Aggarwal, S. & Pittenger, M.F. (2005) Mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815-1822.
2. Anauta, A.J. & Fibbe, W.E. (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood, 110, 3499-3506.
3. Burger, J.A., Tsukada, N., Burger, M., Zvaifler, N.J., Dell'Aquila, M. & Kipps, T.J. (2000) Blood-derived nurse-like cells protect chronic lymphocytic leukaemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood, 96, 2655-2663.
4. Caligaris-Cappio, F. (2003) Role of the microenvironment in chronic lymphocytic leukaemia. British Journal of Haematology, 123, 380-388.
5. Calissano, C., Damle, R.N., Hayes, G., Murphy, E.J., Hellerstein, M.K., Moreno, C., Kaufman, M.S., Kolitz, J.E., Allen, S.L., Rai, K.R. & Chiorazzi, N. (2009) In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukaemia. Blood, 114, 4832-4842.
6. Cheson, B.D., Bennett, J.M., Grever, M., Kay, M.J., O'Brien, S. & Rai, K.R. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukaemia: revised guidelines for diagnosis and treatment. Blood, 87, 4990-4997.
7. Chiorazzi, N., Rai, K.R. & Ferrarini, M. (2005) Chronic lymphocytic leukaemia. New England Journal of Medicine, 35, 804-815.
8. Collins, R.J., Verschuer, L.A., Harmon, B.V., Prentice, R.L., Pope, J.H. & Kerr, J.F. (1989) Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culure in vitro. British Journal of Haematology, 71, 343-350.
9. Cuni, S., Perez-Aciego, P., Perez-Chacon, G., Vargas, J.A., Sanchez, A., Martin-Saavedra, F.M., Ballester, S., García-Marco, J., Jordá,J.& Durántez, A. (2004) A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukaemia B cells. Leukemia, 18, 1391-1400.
10. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutational status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukaemia. Blood, 94, 1840-1847.
11. Danilov, A.V., Danilova, O.V., Klein, A.K. & Huber, B.T. (2006) Molecular pathogenesis of chronic lymphocytic leukaemia. Current Molecular Medicine, 6, 665-675.
12. Deaglio, S., Vaisitti, T., Aydin, S., Ferrero, E. & Malavasi, F. (2006) In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukaemia. Blood, 108, 1135-1144.
13. Deaglio, S., Aydin, S., Grand, M.M., Vaisitti, T., Bergui, L., D'Arena, G., Chiorino, G. & Malavasi, F. (2010) CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukaemia cells. Molecular Medicine, 16, 87-91.
14. DeLisser, H.M., Newman, P.J. & Albelda, S.M. (1994) Molecular and functional aspects of PECAM-1/CD31. Immunology Today, 15, 490-495.
15. Ferrero, E., Belloni, D., Contini, P., Foglieni, C., Ferrero, M.E., Fabbri, M., Poggi, A. & Zocchi, M.R. (2003) Transendothelial migration leads to protection from starvation-induced apoptosis in CD34+ CD14+ circulating precursors: evidence for PECAM-1 involvement through Akt/PKB activation. Blood, 101, 186-193.
16. Fleige, S., Walf, W., Huch, S., Prgomet, C., Sehm, J. & Pfaffl, M.W. (2006) Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Bio-technology Letters, 28, 1601-1613.
17. Gabert, J., Beillard, E., van der Velden, V.H., Bi, W., Grimwade, D., Pallisgaard, N., Barbany, G., Cazzaniga, G., Cayuela, J.M., Cavé, H., Pane, F., Aerts, J.L., De Micheli, D., Thirion, X., Pradel, V., González, M., Viehmann, S., Malec, M., Saglio, G. & van Dongen, J.J. (2003) Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukaemia-a Europe Against Cancer program. Leukemia, 17, 2318-2357.
18. Gao, C., Sun, W., Christofidou-Solomidou, M., Sawada, M., Newman, D.K., Bergom, C., Albelda, S.M., Matsuyama, S. & Newman, P.J. (2003) PECAM-1 functions as a specific potent inhibitor of mitochondrial-dependent apoptosis. Blood, 102, 169-179.
19. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, S.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukaemia. Blood, 94, 1848-1854.
20. Kang, B.-N., Tirumurugaan, K.G., Deshpande, D.A., Amrani, Y., Panettieri, R.A., Walseth, T.F. & Kannan, M.S. (2006) Transcriptional regulation of CD31 expression by tumor necrosis factor-a in human airway smooth muscle cells: role of NF-kB and sensitivity to glucocorticoids. FASEB Journal, 20, E170-E179.
21. Kitada, S., Andersen, J., Akar, S., Zapata, J.M., Takayama, S., Kraiewski, L., Wang, H.G., Zhang, X., Bullrich, F., Croce, C.M., Rai, K., Hines, J. & Reed, J.C. (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukaemia: correlations with in vitro and in vivo chemoresponses. Blood, 91, 3379-3389.
22. Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C. & Stryckmans, P. (1998) Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood, 91, 2387-2396.
23. Longo, P.G., Laurenti, L., Godessi, S., Petlickovski, A., Pelosi, M., Chiusolo, P., Sica, S., Leone, G. & Efremov, D.G. (2007) The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukaemia B-cells from patients with progressive and stable disease. Leukemia, 21, 110-120.
24. Mamdouh, Z., Michailov, A. & Muller, W.A. (2009) Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling complex. Journal of Experimental Medicine, 206, 2795-2808.
25. McConkey, D.J., Chandra, J., Wright, S., Plunkett, W., McDonnel, T.J., Reed, J.C. & Keating, M. (1996) Apoptosis sensitivity in chronic lymphocytic leukaemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. Journal of Immunology, 156, 2624-2630.
26. Meinhardt, G., Wendtner, C.M. & Hallek, M. (1999) Molecular pathogenesis of chronic lymphocytic leukaemia: factors and signaling pathways regulating cell growth and survival. Journal of Molecular Medicine, 77, 282-293.
27. Mollica, S., Montillo, M., Ribatti, D., Mirabelli, R., Tedeschi, A., Ricci, F., Veronese, S., Vacca, A. & Morra, E. (2007) Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukaemia. Hematologica, 92, 1367-1374.
28. Munzert, G., Kirchner, D., Stobbe, H., Bergmann, L., Schmid, R.M., Dohner, H. & Heimpel, H. (2002) Tumor necrosis factor receptor-CD31 Signals to Chronic Lymphocytic Leukaemia Cells associated factor 1 gene overexpression in B-cell chronic lymphocytic leukaemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis. Blood, 100, 3749-3756.
29. Newman, P.J. (1997) The biology of PECAM-1. Journal of Clinical Investigation, 100, S25-S29.
30. Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L. & Hoffbrand, A.V. (1996) Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. British Journal of Haematology, 92, 97-103.
31. Pickering, B.M., de Mel, S., Lee, M., Howell, M., Habens, F., Dallman, C.L., Neville, L.A., Potter, K.N., Mann, J., Mann, D.A., Johnson, P.W., Stevenson, F.K. & Packham, G. (2007) Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells. Oncogene, 26, 1166-1177.
32. Poggi, A., Panzeri, M.C., Moretta, L. & Zocchi, M.R. (1996) CD31- triggered rearrangement of the actin cytoskeleton in human natural killer cells. European Journal of Immunology, 26, 817-824.
33. Poggi, A., Venturino, C., Catellani, S., Clavio, M., Miglino, M., Gobbi, M., Steinle, A., Ghia, P., Stella, S., Caligaris-Cappio, F. & Zocchi, M.R. (2004) Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by transretinoic acid. Cancer Research, 64, 9172-9179.
34. Poggi, A., Catellani, S., Bruzzone, A., Caligaris-Cappio, F., Gobbi, M. & Zocchi, M.R. (2008) Lack of the Leukocyte-associated Ig-like receptor-1 expression in high risk chronic lymphocytic leukemias results in the absence of a negative signal regulating kinase activation and cell division. Leukemia, 22, 980-988.
35. Rai, K.R. & Han, T. (1990) Prognostic factors and clinical staging in chronic lymphocytic leukaemia. Hematology/oncology Clinics of North America, 4, 447-456.
36. Rai, K.R. & Patel, D.V. (1999) Chronic lymphocytic leukaemia. In: Hematology-Basic principles and practice (eds by R. Hoffmann, E.J. Benz & S.J. Shattil et al), pp. Churchill Livingst, New York, 1350-1363.
37. Ringshausen, I., Schneller, F., Bogner, C., Hipp, S., Duyster, J., Peschel, C. & Decker, T. (2002) Constitutively activated phosphatidylinositol-3-kinase (PI-3K) is involved in the defect of apoptosis in B-.CLL: association with protein kinase C delta. Blood, 100, 3741-3748.
38. Sanz, L., Garcia-Marco, J.A., Casanova, B., de La Fuente, M.T., Garcia-Gila, M., Garcia-Pardo, A. & Silva, A. (2004) Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukaemia cells. Biochemical and Biophysical Research Communications, 315, 562-567.
39. Schena, M., Larsson, L.G., Gottardi, D., Gaidano, G., Carlsson, M., Nilsson, K. & Caligaris-Cappio, F. (1992) Growth and differentiation-associated expression of bcl-2 in B chronic lymphocytic leukaemia cells. Blood, 79, 2981-2989.
40. Scielzo, C., Camporeale, A., Geuna, M., Alessio, M., Poggi, A., Zocchi, M.R., Chilosi, M., Caligaris-Cappio, F. & Ghia, P. (2006) Human normal mature B lymphocytes express the T-lymphocyte-related tyrosine kinase ZAP-70. Leukemia, 20, 689-695.
41. Tonino, S.H., Spijker, R., Luijks, D.M., van Oers, M.H. & Kater, A.P. (2008) No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukaemia. Blood, 112, 840-843.
42. Tsukada, N., Burger, J.A., Zvaifler, N.J. & Kipps, T.J. (2002) Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukaemia. Blood, 99, 1030-1037.
43. Turco, M.C., Romano, M.F., Petrella, A., Bisogni, R., Tassone, P. & Venuta, S. (2004) NF-kappaB/Rel-mediated regulation of apoptosis in hematological malignancies and normal hematopoietic progenitors. Leukemia, 18, 11-17.
44. Zocchi, M.R., Ferrero, E., Leone, B.E., Rovere, P., Bianchi, E., Toninelli, E. & Pardi, R. (1996) CD31/PECAM-1-driven chemokine-independent transmigration of human lymphocytes. European Journal of Immunology, 26, 817-824.
45. Zucchetto, A., Benedetti, D., Tripodo, C., Bomben, R., Dal Bo, M., Marconi, D., Bossi, F., Lorenzon, D., Degan, M., Rossi, F.M., Rossi, D., Bulina, P., Franco, V., Del Poeta, G., Deraglio, S., Gaidano, G., Tedesco, F., Malavasi, F. & Gattei, V. (2009) CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Research, 69, 4001-4009.